内部人交易记录
首席财务官尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Elston George, 首席财务官. Insider active across 2 companies, notably EyePoint Pharmaceuticals, Inc.. Cumulatively, 20 disclosures have been recorded. Activity tracked since 9 February 2022. The latest transaction was filed on 20 August 2026 (J). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Elston George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
5,000 股0Common StockSEC:0001429932-26-000010:0
64,953 股0Common StockSEC:0001429932-26-000010:3
5,000 股0Common StockSEC:0001429932-26-000010:1
64,953 股0Common StockSEC:0001429932-26-000010:2
3,627 股@ US$12.93100.0% 占其流量Common StockSEC:0001429932-26-000008:1
7,500 股0Common StockSEC:0001429932-26-000008:0
5,000 股0Common StockSEC:0001429932-26-000006:0
15,285 股0Common StockSEC:0001429932-26-000004:0
19,667 股0Common StockSEC:0001429932-26-000002:0
5,000 股0Common StockSEC:0001429932-25-000007:0
20,000 股0Common StockSEC:0001429932-25-000005:0
7,500 股0Common StockSEC:0001562180-25-004193:0
2,202 股@ US$5.68100.0% 占其流量Common StockSEC:0001562180-25-004193:1
5,834 股0Common StockSEC:0001562180-25-001135:0
15,000 股0Common StockSEC:0001562180-25-000229:0
7,500 股0Common StockSEC:0001562180-24-004462:0
4,967 股0Common StockSEC:0001562180-24-001291:0
15,285 股0Common StockSEC:0001562180-24-000397:0
5,833 股0Common StockSEC:0001562180-23-001331:0
4,966 股0Common StockSEC:0001562180-22-001416:0
About Elston George
Elston George is Chief Financial Officer at EyePoint Pharmaceuticals, Inc. and EyePoint, Inc. He has 16 filings in total. In the 16 sampled recent filings available, the most common transaction nature is option exercise, with buy and sell amounts of EUR 0, and the period runs from 2022-02-11 to 2026-05-27.